Cargando…

Podocyte VEGF-A Knockdown Induces Diffuse Glomerulosclerosis in Diabetic and in eNOS Knockout Mice

Vascular endothelial growth factor-a (VEGF-A) and nitric oxide (NO) are essential for glomerular filtration barrier homeostasis, and are dysregulated in diabetic kidney disease (DKD). While NO availability is consistently low in diabetes, both high and low VEGF-A have been reported in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Veron, Delma, Aggarwal, Pardeep K., Li, Qi, Moeckel, Gilbert, Kashgarian, Michael, Tufro, Alda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906751/ https://www.ncbi.nlm.nih.gov/pubmed/35280251 http://dx.doi.org/10.3389/fphar.2021.788886

Ejemplares similares

Acute Podocyte Vascular Endothelial Growth Factor (VEGF-A) Knockdown Disrupts alpha(V)beta(3) Integrin Signaling in the Glomerulus
por: Veron, Delma, et al.
Publicado: (2012)

Semaphorin3a Promotes Advanced Diabetic Nephropathy
por: Aggarwal, Pardeep K., et al.
Publicado: (2015)

Loss of the podocyte glucocorticoid receptor exacerbates proteinuria after injury
por: Zhou, Han, et al.
Publicado: (2017)

S-Nitrosylation of RhoGAP Myosin9A Is Altered in Advanced Diabetic Kidney Disease
por: Li, Qi, et al.
Publicado: (2021)

Cholesterol Accumulation in Podocytes: A Potential Novel Targetable Pathway in Diabetic Nephropathy
por: Tufro, Alda
Publicado: (2013)

Podocyte-specific Crb2 knockout mice develop focal segmental glomerulosclerosis
por: Tanoue, Akiko, et al.
Publicado: (2021)

Endothelial NO Production Is Mandatory for Epigallocatechin-3-Gallate–induced Vasodilation: Results From eNOS Knockout (eNOS(−/−)) Mice
por: Lorenz, Mario, et al.
Publicado: (2015)

Role of Podocyte Injury in Glomerulosclerosis
por: Lu, Chen-Chen, et al.
Publicado: (2019)

Secondary Focal Segmental Glomerulosclerosis: From Podocyte Injury to Glomerulosclerosis
por: Kim, Jae Seok, et al.
Publicado: (2016)

Role of the eNOS-NO System in Regulating the Antiproteinuric Effects of VEGF Receptor 2 Inhibition in Diabetes
por: Advani, Andrew, et al.
Publicado: (2013)

Mathematical Model Predicts Effective Strategies to Inhibit VEGF-eNOS Signaling
por: Wu, Qianhui, et al.
Publicado: (2020)

A 7-year-old boy with renal insufficiency and proteinuria after stem cell transplant for T-cell acute lymphoblastic leukemia
por: Goodwin, Julie E., et al.
Publicado: (2014)

IGFBP-3 reduces eNOS and PKCzeta phosphorylation, leading to lowered VEGF levels
por: Zhang, Qiuhua, et al.
Publicado: (2015)

Molecular mechanisms underlying pharmacological stimulation of eNOS expression and eNOS activity
por: Li, Huige, et al.
Publicado: (2009)

Angiopoietin-like-3 knockout protects against glomerulosclerosis in murine adriamycin-induced nephropathy by attenuating podocyte loss
por: Dai, Rufeng, et al.
Publicado: (2019)

TNF-α and IL-1β Promote Renal Podocyte Injury in T2DM Rats by Decreasing Glomerular VEGF/eNOS Expression Levels and Altering Hemodynamic Parameters
por: Wang, Jufang, et al.
Publicado: (2022)

PKC-Dependent Phosphorylation of eNOS at T495 Regulates eNOS Coupling and Endothelial Barrier Function in Response to G(+) -Toxins
por: Chen, Feng, et al.
Publicado: (2014)

Computer Simulation of TSP1 Inhibition of VEGF–Akt–eNOS: An Angiogenesis Triple Threat
por: Bazzazi, Hojjat, et al.
Publicado: (2018)

A multicolor podocyte reporter highlights heterogeneous podocyte changes in focal segmental glomerulosclerosis
por: Tao, Jianling, et al.
Publicado: (2013)

VEGF and eNOS Expression in Umbilical Cord from Pregnancy Complicated by Hypertensive Disorder with Different Severity
por: Bhavina, K., et al.
Publicado: (2014)

Circulating VEGF and eNOS variations as predictors of outcome in metastatic colorectal cancer patients receiving bevacizumab
por: Marisi, Giorgia, et al.
Publicado: (2017)

Heterozygous eNOS Deficient Mice as a Model to Examine the Effects of eNOS Haploinsufficiency on the Cerebral Circulation
por: Didion, Sean P.
Publicado: (2017)

mTOR contributes to endothelium-dependent vasorelaxation by promoting eNOS expression and preventing eNOS uncoupling
por: Wang, Yiying, et al.
Publicado: (2022)

Mid-dose losartan mitigates diabetes-induced hepatic damage by regulating iNOS, eNOS, VEGF, and NF-κB expressions
por: OLTULU, Fatih, et al.
Publicado: (2019)

Role of Endothelial Nitric Oxide Synthase in Diabetic Nephropathy: Lessons from Diabetic eNOS Knockout Mice
por: Takahashi, Takamune, et al.
Publicado: (2014)

Interstitial inflammation and interstitial fibrosis and tubular atrophy predict renal survival in lupus nephritis
por: Wilson, Parker C, et al.
Publicado: (2018)

Mineralocorticoid Receptor Blocker Protects against Podocyte-Dependent Glomerulosclerosis
por: Takagi, Nobuaki, et al.
Publicado: (2012)

A Case of Podocytic Infolding Glomerulopathy with Focal Segmental Glomerulosclerosis
por: Iguchi, Akira, et al.
Publicado: (2013)

Podocyte and endothelial injury in focal segmental glomerulosclerosis: an ultrastructural analysis
por: Taneda, Sekiko, et al.
Publicado: (2015)

Loss of decay-accelerating factor triggers podocyte injury and glomerulosclerosis
por: Angeletti, Andrea, et al.
Publicado: (2020)

Different expressions of AQP1, AQP4, eNOS, and VEGF proteins in ischemic versus non-ischemic cerebropathy in rats: potential roles of AQP1 and eNOS in hydrocephalic and vasogenic edema formation
por: Kim, Jaehyun, et al.
Publicado: (2011)

Association of genetic polymorphisms of eNOS with glaucoma
por: Liao, Qiong, et al.
Publicado: (2011)

Ursolic acid prevents doxorubicin‐induced cardiac toxicity in mice through eNOS activation and inhibition of eNOS uncoupling
por: Mu, Haiman, et al.
Publicado: (2019)

Multiple inducers of endothelial NOS (eNOS) dysfunction in sickle cell disease
por: Hebbel, Robert P., et al.
Publicado: (2021)

Upregulation of iNOS and phosphorylated eNOS in the implantation‐induced blastocysts of mice
por: Seki, Misato, et al.
Publicado: (2023)

Prospective validation of VEGF and eNOS polymorphisms as predictors of first-line bevacizumab efficacy in patients with metastatic colorectal cancer
por: Marisi, Giorgia, et al.
Publicado: (2023)

Data on eNOS T786 and G894T polymorphisms and peripheral blood eNOS mRNA levels in Sickle Cell Disease
por: Armenis, Iakovos, et al.
Publicado: (2016)

Proteomics of Plasma and Plasma-Treated Podocytes: Application to Focal and Segmental Glomerulosclerosis
por: Chhuon, Cerina, et al.
Publicado: (2023)

Therapeutic Potential Targeting Podocyte Mitochondrial Dysfunction in Focal Segmental Glomerulosclerosis
por: Li, Yuting, et al.
Publicado: (2023)

Basal Vascular Smooth Muscle Cell Tone in eNOS Knockout Mice Can Be Reversed by Cyclic Stretch and Is Independent of Age
por: De Moudt, Sofie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_81427u51vjsb48aan63ntoid69